SC 13G | 2018-01-10 | JPMORGAN CHASE & CO | INTERCEPT PHARMACEUTICALS INC | 2,007,198 | 7.9% | EDGAR |
SC 13G/A | 2017-11-09 | AMERIPRISE FINANCIAL INC | INTERCEPT PHARMACEUTICALS INC | 1,185,405 | 4.7% | EDGAR |
SC 13G/A | 2017-02-14 | FMR LLC | INTERCEPT PHARMACEUTICALS INC | 3,721,316 | 15.0% | EDGAR |
SC 13G/A | 2017-02-13 | Capital World Investors | INTERCEPT PHARMACEUTICALS INC | 2,142,459 | 8.6% | EDGAR |
SC 13G/A | 2017-02-10 | AMERIPRISE FINANCIAL INC | INTERCEPT PHARMACEUTICALS INC | 2,507,900 | 10.1% | EDGAR |
SC 13G/A | 2017-02-07 | Carmignac Gestion | INTERCEPT PHARMACEUTICALS INC | 2,022,792 | 8.2% | EDGAR |
SC 13G/A | 2016-02-12 | FMR LLC | INTERCEPT PHARMACEUTICALS INC | 3,649,728 | 15.0% | EDGAR |
SC 13G | 2016-02-12 | Capital World Investors | INTERCEPT PHARMACEUTICALS INC | 1,567,537 | 6.4% | EDGAR |
SC 13G/A | 2016-02-09 | Carmignac Gestion | INTERCEPT PHARMACEUTICALS INC | 1,319,887 | 5.4% | EDGAR |
SC 13G | 2016-01-11 | AMERIPRISE FINANCIAL INC | INTERCEPT PHARMACEUTICALS INC | 2,863,068 | 11.8% | EDGAR |
SC 13D/A | 2015-03-30 | ORBIMED ADVISORS LLC | INTERCEPT PHARMACEUTICALS INC | 1,120,324 | 5.0% | EDGAR |
SC 13D/A | 2015-03-25 | ORBIMED ADVISORS LLC | INTERCEPT PHARMACEUTICALS INC | 1,277,524 | 5.6% | EDGAR |
SC 13G/A | 2015-02-17 | Genextra S.p.A. | INTERCEPT PHARMACEUTICALS INC | 6,454,953 | 28.6% | EDGAR |
SC 13G/A | 2015-02-13 | FMR LLC | INTERCEPT PHARMACEUTICALS INC | 3,203,951 | 15.0% | EDGAR |
SC 13G/A | 2015-02-13 | Visium Asset Management, LP | INTERCEPT PHARMACEUTICALS INC | 80 | 0.0% | EDGAR |
SC 13G | 2015-02-09 | Carmignac Gestion | INTERCEPT PHARMACEUTICALS INC | 1,432,071 | 6.7% | EDGAR |
SC 13D/A | 2014-08-28 | ORBIMED ADVISORS LLC | INTERCEPT PHARMACEUTICALS INC | 1,485,324 | 7.0% | EDGAR |
SC 13D/A | 2014-04-11 | ORBIMED ADVISORS LLC | INTERCEPT PHARMACEUTICALS INC | 1,656,258 | 8.2% | EDGAR |
SC 13G/A | 2014-04-03 | SAC Capital Advisors LP | INTERCEPT PHARMACEUTICALS INC | 6,123 | 0.0% | EDGAR |
SC 13G/A | 2014-02-14 | FMR LLC | INTERCEPT PHARMACEUTICALS INC | 2,663,980 | 13.8% | EDGAR |